Hemab Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Hemab Therapeutics's estimated annual revenue is currently $10.2M per year.
- Hemab Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Hemab Therapeutics has 66 Employees.
- Hemab Therapeutics grew their employee count by 22% last year.
Hemab Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CMO | Reveal Email/Phone |
2 | VP Regulatory Affairs | Reveal Email/Phone |
3 | SVP, Development Operations | Reveal Email/Phone |
4 | VP, Head Clinical Operations | Reveal Email/Phone |
5 | SVP, Development Operations | Reveal Email/Phone |
6 | VP Research | Reveal Email/Phone |
7 | Director Medical Affairs and Global External Engagement | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Director Regulatory Affairs | Reveal Email/Phone |
10 | Associate Director, Medical Science | Reveal Email/Phone |
Hemab Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Hemab Therapeutics?
Hemab ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.
keywords:N/A
N/A
Total Funding
66
Number of Employees
$10.2M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hemab Therapeutics News
Maraganore serves as the chair of Hemab Therapeutics and as a director of Agios Pharmaceuticals, Beam Therapeutics, and Kymera Therapeutics. He...
He has taken board positions at Hemab Therapeutics, Kymera Therapeutics and Rain Therapeutics. Maraganore has also been tapped to serve as a...
Other Companies in Copenhagen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $13.5M | 66 | 6% | N/A |
#2 | $10.2M | 66 | 43% | N/A |
#3 | $23M | 66 | 53% | N/A |
#4 | $12.5M | 66 | -22% | N/A |
#5 | $9.3M | 67 | -25% | N/A |